Skip to Content

  • Search

View Additional Section Content

A Randomized Double-blind Placebo-Controlled Trial of Neratinib (HKI-272) After Trastuzumab in Women With Early-Stage HER-2/neu Overexpressed/Amplified Breast Cancer

Principal Investigator(s)
Jessica A. Berman, M.D.
Robert A. Maxwell, M.D. (Sub-Investigator)
Peter V. Pickens, M.D. (Sub-Investigator)
Joseph L. Potz, M.D. (Sub-Investigator)
Marc J. Chernoff, D.O. (Sub-Investigator)
Vishwanath Gharpure, M.D. (Sub-Investigator)
Jason A. Damsker, M.D. (Sub-Investigator)
Felice LePar, M.D. (Sub-Investigator)
Pallav Mehta, M.D. (Sub-Investigator)
Michael J. Seidman, M.D. (Sub-Investigator)

Clinical Trial Categories

  • Breast Cancer
Diane Foley, CCRP at 215-692-3213


  • Abington Hematology/Oncology Associates
    Abington Health Center - Schilling
    2510 Maryland Rd, Ste 175
    Willow Grove, PA 19090-1108
    Office: 215-706-2034
    Fax: 215-706-4176

Find a Physician
Search Our Directory


Schedule a


Clinical Trials Details